U.S. Wireless Telecom Stock News

Summit Therapeutics Inc. has already reported first-quarter 2026 results, with net loss widening to US$189.42 million and basic and diluted loss per share from continuing operations at US$0.24, compared with US$62.91 million and US$0.09 a year earlier. This sharp increase in quarterly losses may prompt investors to reassess how Summit’s spending and cash use align with its late-stage oncology pipeline. Next, we’ll examine how this much larger quarterly net loss shapes Summit’s existing...

Why Select Medical Holdings Is On Investors’ Radar Today Select Medical Holdings (SEM) has drawn fresh attention after recent share price moves and updated return figures, prompting investors to reassess how its hospital and rehabilitation footprint fits into their portfolios. See our latest analysis for Select Medical Holdings. At a share price of $16.44, SEM’s recent 90 day share price return of 4.78% and year to date share price return of 10.93% sit alongside a 1 year total shareholder...

ConocoPhillips reported first-quarter 2026 results showing revenue of US$16.05 billion and net income of US$2.18 billion, alongside a maintained ordinary dividend of US$0.84 per share. Beyond the headline earnings, the company highlighted slightly lower production and the impact of Middle East-related downtime, while progressing Norwegian gas field restarts that could support Europe’s energy security over time. We’ll now examine how the solid dividend declaration amid slightly lower...

Earlier this month, Skyworks Solutions reported that second-quarter 2026 sales edged down to US$943.7 million while net income and earnings per share from continuing operations declined versus a year ago, and the company affirmed a quarterly dividend of US$0.71 per share alongside third-quarter revenue guidance of US$900 million to US$950 million. Amid these results, Skyworks also highlighted a new multi-generation Android OEM partnership and the launch of its Si86Px digital isolator family,...

Wondering whether NCR Voyix at US$8.09 is starting to look cheap, or still carries too much risk for the price you pay? The stock has moved sharply in the short term, with a 17.4% return over 7 days and 29.2% over 30 days, although returns are negative at 18.0% year to date and 20.4% over 1 year. These recent moves sit against a longer track record that includes 42.7% and 71.8% returns over 3 and 5 years respectively. These figures may reflect shifting sentiment and changing expectations for...

Extra Space Storage (EXR) shares were in focus after first quarter 2026 results showed sales of US$733.21 million and total revenue of US$856.03 million, alongside lower net income and earnings per share year over year. See our latest analysis for Extra Space Storage. The first quarter update and ongoing share repurchases came against a backdrop of a 7.76% 1 month share price return and a 9.39% year to date share price return, while the 1 year total shareholder return of 1.71% points to more...

Key business profile and recent share performance ESCO Technologies (ESE) has drawn fresh attention after its recent share move, with the stock last closing at $332.77 and showing positive returns over the past week, month and past 3 months. For investors tracking longer horizons, ESCO Technologies has also recorded positive total returns year to date, over the past year, and across the past 3 and 5 years. This context helps frame the current valuation conversation. See our latest analysis...

Dole plc recently prepared to report its first-quarter results amid rising shipping costs, softer European demand tied to the Iran conflict, and currency pressures, raising concerns about already thin margins. At the same time, Disney Springs’ Swirls on the Water introduced a new DOLE Whip Flight, underscoring the enduring consumer appeal of Dole-branded treats in experiential leisure settings. We’ll now explore how expectations around Dole’s earnings resilience under higher shipping costs...

Zimmer Biomet Holdings reported past first-quarter 2026 results with sales of US$2,086.7 million and net income of US$238.1 million, reaffirming its full-year revenue guidance. Alongside continued share repurchases, the company announced the departure of its CFO and appointed its Controller and Chief Accounting Officer as interim CFO, raising questions about leadership continuity in its finance function. Next, we’ll examine how reaffirmed guidance alongside the CFO transition may influence...

Apple’s recent performance and scale Apple (AAPL) is drawing investor attention as its stock recently closed at $293.32, with returns of 2% over the past day, 4.7% over the past week, and 12.6% over the past month. Over the past 3 months, the stock shows a 6.8% return, while the 1 year total return stands at 48.4%. Longer term, Apple’s 3 year and 5 year total returns are 72.2% and 135.9% respectively, illustrating sizeable compounding over time. The company operates at a large scale,...

Shift4 Payments (FOUR) is back in focus after its first quarter 2026 earnings, reporting revenue of US$1.12b and net income of US$15 million, along with new high profile sports venue partnerships. See our latest analysis for Shift4 Payments. The stock reacted sharply to the Q1 2026 update, with a 1-day share price return of 9.26% and a 30-day share price return of 16.34%. However, the year-to-date share price return of 25.26% and 1-year total shareholder return of 45.16% both remain weak,...

If you are wondering whether Altria Group stock still offers value at around US$69.04, it helps to start by lining up its price against what the fundamentals suggest. The stock has seen a 5.0% decline over the last 7 days, while returns sit at 4.2% over 30 days, 20.5% year to date and 22.3% over 1 year, with very large gains over 3 and 5 years of 91.1% and 103.3% respectively, which can change how you think about both opportunity and risk. Recent coverage has focused on Altria Group's...

ICON stock performance snapshot after recent moves ICON (ICLR) has caught investor attention after a recent share price move, with the stock closing at $125. Short term returns show mixed momentum, including a 0.7% gain over the past day. Over the past week and month, ICON has recorded returns of 5.6% and 16.6% respectively. Performance over the past 3 months and year to date reflects double digit declines, highlighting uneven sentiment around the stock. See our latest analysis for ICON. That...

Why F5’s latest quarter is back in focus F5 (FFIV) is back on investors’ radar after reporting quarterly results that showed higher revenue and profit, raising full year revenue growth guidance and pointing to firm demand in hybrid multicloud and application security. See our latest analysis for F5. That upbeat earnings release sits alongside strong recent share price momentum, with a 1-day share price return of 1.17% and a 90-day share price return of 24.75%. The 3-year total shareholder...

In early May 2026, Innoviva, Inc. reported first-quarter 2026 results, with revenue of US$97.99 million and net income of US$186.6 million, marking a clear turnaround from the prior year’s loss. Around the same time, Innoviva filed a US$207.99 million shelf registration for up to 9,000,000 common shares tied to its employee stock ownership plan, underscoring management’s focus on employee alignment alongside growth in its recurring royalty and Specialty Therapeutics businesses. We’ll now...

In the first quarter of 2026, PDF Solutions, Inc. reported revenue of US$60.13 million, up from US$47.78 million a year earlier, swinging from a net loss of US$3.03 million to net income of US$4.79 million, and reaffirmed guidance for 20% annual revenue growth for 2026. Management highlighted strong momentum in its Exensio and Cimetrix software platforms, growing interest in AI-enabled analytics, and continued build-out of its eProbe inspection systems as it works toward higher long-term...

What Genworth’s latest quarter tells you about the stock Genworth Financial (GNW) put fresh numbers on the table with its first quarter 2026 report, pairing flat revenue and lower net income with stronger operating cash flow and active share repurchases. See our latest analysis for Genworth Financial. Genworth’s share price has held close to US$9.14 despite a 5.9% 1 month share price return and a 30.2% 1 year total shareholder return, which suggests that recent earnings softness and active...

Why IDEX (IEX) is back on investors’ radar IDEX (IEX) has drawn fresh attention after reporting first quarter 2026 results with higher sales and net income, declaring its 126th consecutive quarterly dividend and updating investors on completed share repurchases. See our latest analysis for IDEX. The earnings beat, long dividend record and fresh buyback activity come after a strong run, with a 30 day share price return of 12.01% and a 1 year total shareholder return of 18.18%, suggesting...

Piper Sandler Companies (PIPR) has put capital returns in focus after reporting first quarter 2026 results, pairing higher revenue with a 14% lift in its quarterly dividend and ongoing share repurchases. See our latest analysis for Piper Sandler Companies. Despite the recent earnings release, the stock has seen a 7.73% 7 day share price decline and an 8.04% year to date share price decline. However, the 1 year total shareholder return of 28.89% and very large 3 and 5 year total shareholder...

Setting the scene for Asana stock Asana (ASAN) has been on investors’ radar after recent trading, with the stock closing at $7.05. With mixed short and longer term returns, many are reassessing how its work management platform fits their portfolio. See our latest analysis for Asana. Recent trading has pushed Asana’s 7 day share price return to 11.55% and 30 day return to 13.71%. However, the year to date share price return of 45.60% and 1 year total shareholder return of 59.13% indicate that...

Why Catalyst Pharmaceuticals Stock Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) has drawn attention after a period of strong share-price moves, with returns over the past month, past 3 months and year all in positive territory according to recent performance data. For investors tracking US biopharmaceutical stocks focused on rare diseases, this kind of sustained positive return profile can prompt a closer look at how the current share price relates to earnings, profitability and...

SoFi Technologies (SOFI) has drawn fresh attention after reporting Q1 2026 earnings that included US$1.1b in net revenue, net income of US$166.7 million, and record loan and deposit balances. See our latest analysis for SoFi Technologies. Despite strong Q1 results, SoFi’s recent 1-day and 90-day share price returns of 1.84% and 23.3% declines contrast with a 1-year total shareholder return of 20.66% and a 3-year total shareholder return above 3x. This points to fading near term momentum but...

Why Danaher Stock Is On Investors’ Radar Now Danaher (DHR) has drawn fresh attention after recent share price moves, with the stock showing a return of about 0.4% over the past day but weaker performance across the month and past 3 months. See our latest analysis for Danaher. At a share price of $175.66, Danaher's recent 30 day share price return of an 8.0% decline and year to date share price return of a 23.8% decline suggest momentum has been fading, despite a smaller 9.2% decline in the 1...

Why Hawkins (HWKN) Is On Investors’ Radar Recent trading in Hawkins (HWKN) has drawn attention after the stock’s recent month and past 3 months performance, prompting investors to reassess what the current price of $167.01 implies. With returns of 13.88% over the past month and 24.28% in the past 3 months, Hawkins’ recent move sits against a backdrop of longer term total returns and a business spanning water treatment, industrial chemicals, and health and nutrition ingredients. See our latest...